Transcriptomics Technologies Market Outlook:
Transcriptomics Technologies Market size was over USD 8.01 billion in 2025 and is poised to exceed USD 18.11 billion by 2035, witnessing over 8.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of transcriptomics technologies is estimated at USD 8.62 billion.
It is anticipated that companies in the worldwide market would have abundant growth prospects due to the rising incidence of cancer. The American Cancer Society projects that in 2019, there will be 606,880 cancer-related deaths in the United States and 1,762,450 new instances of cancer identified.
In addition to these, the ongoing enhancement of the healthcare infrastructure and the growing investments in research & development are giving the market a significant boost in growth. The necessity for drug research and development is underscored by the global incidence of diseases including diabetes, hepatitis B, and cancer, which is also a major factor propelling the transcriptomics technologies market.
